Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | FGB | P02675 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.31 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23587441 | 0.89 | NPSR1 (0.37) | CA2ELANENPSR1NQO2MEN1 | |
| SCHEMBL23960174 | 0.87 | ELANE (0.35) | CA2ELANENPSR1KDM1A | |
| SCHEMBL23587428 | 0.87 | LMNA (0.33) | NPSR1NQO2MEN1KMT2AALDH1A1 | |
| SCHEMBL23587443 | 0.81 | NPSR1 (0.37) | CA2ELANENPSR1NQO2MEN1 | |
| SCHEMBL18615296 | 0.79 | MEN1 (0.37) | CA2ELANENPSR1MEN1KMT2A | |
| SCHEMBL21755770 | 0.79 | NPSR1 (0.32) | CA2NPSR1 | |
| SCHEMBL23960175 | 0.78 | NPSR1 (0.38) | CA2ELANENPSR1MEN1KMT2A | |
| SCHEMBL18615248 | 0.77 | NPSR1 (0.42) | CA2ELANENPSR1MEN1KMT2A | |
| SCHEMBL18613104 | 0.77 | ELANE (0.38) | CA2ELANENPSR1KMT2AALDH1A1 | |
| SCHEMBL21755780 | 0.76 | SIRT2 (0.36) | MEN1KMT2AALDH1A1FGBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210331994-A1 | COMPOUND, COMPOSITION CONTAINING THE SAME, METHOD FOR FORMING RESIST PATTERN AND METHOD FOR FORMING INSULATING FILM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-10-28 | — | — | US | disclosed |
| EP-3842491-A1 | COMPOUND, COMPOSITION CONTAINING THE SAME, METHOD FOR FORMING RESIST PATTERN, AND METHOD FOR FORMING INSULATING FILM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210331994-A1 | COMPOUND, COMPOSITION CONTAINING THE SAME, METHOD FOR FORMING RESIST PATTERN AND METHOD FOR FORMING INSULATING FILM | BMI1, PRDM9, CTCF | CA2 4386/4885ELANE 3153/4885NPSR1 3828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.